Amryt Pharma Says European Commission Oks Filsuvez For Dystrophic And Junctional EB

Amryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDA

Biopharmaceutical company Amryt Pharma plc (AMYT) announced Friday that the company plans to submit a Formal Dispute Resolution Request (FDRR) for the company's New Drug Application (NDA) for Oleogel-S10 (Filsuvez), for the treatment of the cutaneous manifestations of Dystrophic and Junctional Epidermolysis Bullosa (EB).

RTTNews | 1183天前

Swiss Market Ends Higher For 2nd Straight Session

The Switzerland market opened on a slightly weak note on Friday, but recovered swiftly and then kept edging higher to eventually end the day's session on a firm note.

RTTNews | 5小時4分鐘前

Major European Markets Close Slightly Weak

The major European markets closed slightly down on Friday as investors assessed recent moves of the central banks and weighed the potential impact of tariffs. A bit of profit taking also contributed to the market's weak close.

RTTNews | 5小時29分鐘前

TSX Marches On, Hits Fresh Record High; Materials Stocks Rally

The Canadian market is up firmly in positive territory a little past noon on Friday, extending recent gains, thanks largely to strong buying in the materials sector. Energy stocks are struggling for support due to weak oil prices. The mood remains fairly bullish amid expectations the Bank of Canada and the Federal Reserve will announce further easing this year to boost growth.

RTTNews | 6小時34分鐘前

Bank Of Japan Holds Rate Steady; Plans To Lower ETF Holdings

The Japanese central bank left its key interest rate unchanged on Friday, as expected, but surprised markets with a decision to reduce the holdings of its massive stock of exchange-traded funds, suggesting that the monetary policy normalization is underway. The Bank of Japan policy board, led by Governor Kazuo Ueda, voted 7-2 to hold the uncollateralized overnight call rate at around 0.5 percen

RTTNews | 9小時30分鐘前